CSF2 and neoplasm: GM-CSF has been safely used as an adjuvant in tumor cell– and peptide-based vaccines in murine models and in human trials, but IL-12 given systemically has resulted in fatal toxicity (36), raising concerns about the safety of this approach for human translation.